内皮祖细胞功能障碍：机制与治疗方法。 - Suppr

Suppr

超能文献

Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches.

作者信息

Bauersachs J, Thum T

机构信息

Medizinische Klinik und Poliklinik I, Kardiologie, Julius-Maximilians-Universität Würzburg, Germany.

出版信息

Eur J Clin Invest. 2007 Aug;37(8):603-6. doi: 10.1111/j.1365-2362.2007.01833.x.

DOI:10.1111/j.1365-2362.2007.01833.x

PMID:17635570

Abstract

摘要

相似文献

Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches.

Eur J Clin Invest. 2007 Aug;37(8):603-6. doi: 10.1111/j.1365-2362.2007.01833.x.

Potential manipulation of endothelial progenitor cells in diabetes and its complications.

Diabetes Obes Metab. 2010 Jul;12(7):570-83. doi: 10.1111/j.1463-1326.2010.01210.x.

The promise of EPC-based therapies on vascular dysfunction in diabetes.

Eur J Pharmacol. 2011 Nov 1;669(1-3):1-6. doi: 10.1016/j.ejphar.2011.07.035. Epub 2011 Aug 5.

Significance of endothelial progenitor cells in subjects with diabetes.

Diabetes Care. 2007 May;30(5):1305-13. doi: 10.2337/dc06-2305. Epub 2007 Feb 2.

[Endothelial dysfunction and plaque inflammation in diabetic macroangiopathy].

Nihon Rinsho. 2006 Nov;64(11):1980-3.

Effects of insulin resistance on endothelial progenitor cells and vascular repair.

Clin Sci (Lond). 2009 Aug 3;117(5):173-90. doi: 10.1042/CS20080263.

Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):401-3. doi: 10.1097/HJR.0b013e32832d3c76.

Endothelial progenitor cells in health and atherosclerotic disease.

Ann Med. 2007;39(2):82-90. doi: 10.1080/07853890601073429.

Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):464-71. doi: 10.1097/HJR.0b013e32832b38be.

[Number and function of circulating endothelial progenitor cell in diabetics with different vascular complications].

Zhonghua Yi Xue Za Zhi. 2009 May 12;89(18):1234-9.

引用本文的文献

The Cell Type-Specific Functions of miR-21 in Cardiovascular Diseases.

Front Genet. 2020 Nov 20;11:563166. doi: 10.3389/fgene.2020.563166. eCollection 2020.

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.

Drug Deliv Transl Res. 2018 Aug;8(4):954-963. doi: 10.1007/s13346-017-0412-5.

Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.

Antioxid Redox Signal. 2011 Aug 15;15(4):933-48. doi: 10.1089/ars.2010.3502. Epub 2010 Dec 13.

Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.

Atherosclerosis. 2010 Jul;211(1):297-302. doi: 10.1016/j.atherosclerosis.2010.01.036. Epub 2010 Feb 4.

The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function.

Mol Med. 2008 May-Jun;14(5-6):235-7. doi: 10.2119/2008-00037.Fleissner.

Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

Cardiovasc Res. 2008 May 1;78(2):265-73. doi: 10.1093/cvr/cvn039. Epub 2008 Feb 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches.

作者信息

Bauersachs J, Thum T

机构信息

Medizinische Klinik und Poliklinik I, Kardiologie, Julius-Maximilians-Universität Würzburg, Germany.

出版信息

Eur J Clin Invest. 2007 Aug;37(8):603-6. doi: 10.1111/j.1365-2362.2007.01833.x.

DOI:10.1111/j.1365-2362.2007.01833.x

PMID:17635570

Abstract

摘要

相似文献

Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches.

Eur J Clin Invest. 2007 Aug;37(8):603-6. doi: 10.1111/j.1365-2362.2007.01833.x.

Potential manipulation of endothelial progenitor cells in diabetes and its complications.

Diabetes Obes Metab. 2010 Jul;12(7):570-83. doi: 10.1111/j.1463-1326.2010.01210.x.

The promise of EPC-based therapies on vascular dysfunction in diabetes.

Eur J Pharmacol. 2011 Nov 1;669(1-3):1-6. doi: 10.1016/j.ejphar.2011.07.035. Epub 2011 Aug 5.

Significance of endothelial progenitor cells in subjects with diabetes.

Diabetes Care. 2007 May;30(5):1305-13. doi: 10.2337/dc06-2305. Epub 2007 Feb 2.

[Endothelial dysfunction and plaque inflammation in diabetic macroangiopathy].

Nihon Rinsho. 2006 Nov;64(11):1980-3.

Effects of insulin resistance on endothelial progenitor cells and vascular repair.

Clin Sci (Lond). 2009 Aug 3;117(5):173-90. doi: 10.1042/CS20080263.

Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):401-3. doi: 10.1097/HJR.0b013e32832d3c76.

Endothelial progenitor cells in health and atherosclerotic disease.

Ann Med. 2007;39(2):82-90. doi: 10.1080/07853890601073429.

Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):464-71. doi: 10.1097/HJR.0b013e32832b38be.

[Number and function of circulating endothelial progenitor cell in diabetics with different vascular complications].

Zhonghua Yi Xue Za Zhi. 2009 May 12;89(18):1234-9.

引用本文的文献

The Cell Type-Specific Functions of miR-21 in Cardiovascular Diseases.

Front Genet. 2020 Nov 20;11:563166. doi: 10.3389/fgene.2020.563166. eCollection 2020.

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.

Drug Deliv Transl Res. 2018 Aug;8(4):954-963. doi: 10.1007/s13346-017-0412-5.

Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.

Antioxid Redox Signal. 2011 Aug 15;15(4):933-48. doi: 10.1089/ars.2010.3502. Epub 2010 Dec 13.

Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.

Atherosclerosis. 2010 Jul;211(1):297-302. doi: 10.1016/j.atherosclerosis.2010.01.036. Epub 2010 Feb 4.

The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function.

Mol Med. 2008 May-Jun;14(5-6):235-7. doi: 10.2119/2008-00037.Fleissner.

Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

Cardiovasc Res. 2008 May 1;78(2):265-73. doi: 10.1093/cvr/cvn039. Epub 2008 Feb 15.